-Abida Haque Researcher Activity Profile

Research Author Detailed Information 

Abida Haque Publication Rate By Year

Abida Haque has published 1 paper(s) in 1986, 1 paper(s) in 1995, 1 paper(s) in 2001, 2 paper(s) in 2004, 5 paper(s) in 2006, 13 paper(s) in 2007, 6 paper(s) in 2008, for a total of 29 research publications in total.

Abida A Haque Author Information

LAST NAME: haque

FIRST NAME: Abida

INITIALS: a

AFFILIATION:

Papers

Abida Haque's Publication Record

1. MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival. Year Published: 2007
Department of Pathology, Baylor College of Medicine, Houston, Tex, USA.
2. Transformed migraine is a cause of chronic daily headaches. Year Published: 2004
From the Cerebral Blood Flow Laboratory, Veterans Administration Medical Center, Houston, Tex.
3. Mannose-conjugated alendronate selectively depletes Kupffer cells and inhibits endotoxemic shock in the mice. Year Published: 2006
Department of Biochemistry & Molecular Pathology, Osaka City University Medical School, Osaka 545-8585, Japan.
4. Activation of the hedgehog pathway in a subset of lung cancers. Year Published: 2006
Department of Pharmacology, Sealy Center for Cancer Cell Biology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1048, USA.
5. A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. Year Published: 2006
London School of Hygiene and Tropical Medicine, London, United Kingdom. ashraful.haque@qimr.edu.au
6. Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo. Year Published: 2006
Department of Biochemistry & Molecular Pathology, Osaka City University Medical School, Osaka 545-8585, Japan.
7. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. Year Published: 2006
London School of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom.
8. Early detection of typhoid by polymerase chain reaction. Year Published: 2007
National Institute for Biotechnology and Genetic Engineering (NIBGE), and Department of Pathology, Punjab Medical College, Faisalabad, Pakistan.
9. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells. Year Published: 2007
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
10. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Year Published: 2007
Division of Pediatric Critical Care Medicine, Suite 5121 Doctors Office Tower, 2200 Children's Way, Nashville, TN 37232-9075, USA. vshankarmd@mac.com
11. Factors influencing survival among patients with vascular dementia and Alzheimer's disease. Year Published: 2007
Cerebrovascular Research Laboratory and Radiology Service, Veterans Affairs Medical Center, Houston, TX USA; Department of Neurology Baylor College of Medicine, Houston, TX USA; Department of Neurology Baylor College of Medicine, Houston, TX USA.
12. Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. Year Published: 2007
Department of Neurosciences, Division of Neurology, Medical University of South Carolina, Charleston, SC 29425, USA.
13. Emerging Role of Combination of All-trans Retinoic Acid and Interferon-gamma as Chemoimmunotherapy in the Management of Human Glioblastoma. Year Published: 2007
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, 29425, USA.
14. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance. Year Published: 2007
Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230-1402, USA. hkantarj@mdanderson.org
15. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Year Published: 2007
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
16. Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. Year Published: 2007
Department of Neurosciences, Division of Neurology, Medical University of South Carolina, Charleston, SC 29425, USA.
17. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Year Published: 2007
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
18. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance. Year Published: 2007
Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230-1402, USA. hkantarj@mdanderson.org
19. Defects in HLA class II antigen presentation in B-cell lymphomas. Year Published: 2008
Department of Microbiology and Immunology.
20. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Year Published: 2007
Division of Pediatric Critical Care Medicine, Suite 5121 Doctors Office Tower, 2200 Children's Way, Nashville, TN 37232-9075, USA. vshankarmd@mac.com
21. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Year Published: 2008
Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA. haque@musc.edu
22. Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines. Year Published: 2008
Centre National de la Recherche Scientifique, Paris, France; Dartmouth Medical School, Lebanon, New Hampshire, USA; and Université Lille 2, Lille, France.
23. Rheumatic fever and carditis at the National Institute of Cardio-Vascular Diseases--a follow up study. Year Published: 1986
24. Recovery of gaze stability during vestibular regeneration. Year Published: 2008
Dept. of Anatomy and Neurobiology, Box 8108, 660 S. Euclid, Washington University School of Medicine, St. Louis, MO 63110. ddickman@wustl.edu).
25. Head unrestrained horizontal gaze shifts after unilateral labyrinthectomy in the rhesus monkey. Year Published: 2001
Department of Otolaryngology, University of Texas Medical Branch, Galveston, TX 77555-0521, USA. sdnewlan@utmb.edu
26. Spatial tuning and dynamics of vestibular semicircular canal afferents in rhesus monkeys. Year Published: 2004
Department of Otolaryngology, Washington University School of Medicine, 660 South Euclid, St Louis, MO 63110, USA.
27. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Year Published: 2008
Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA. haque@musc.edu
28. Study of HTLV-I antibodies in CSF and serum of neurolathyrism patients in Bangladesh. Year Published: 1995
Department of Neurology, Institute for Postgraduate Medicine and Research, Dhaka, Bangladesh.
29. Defects in HLA class II antigen presentation in B-cell lymphomas. Year Published: 2008